Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,101.9
9.8 (0.32%)

 

  • STI Straits Times Index
    3,101.9
    9.8 (0.32%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,501.7
    4.8 (0.32%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,766.7
    -22.2 (-0.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,607.4
    33.6 (0.94%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 818.5M
  • Value: 1,115.1M
  • Rise: 182
  • Fall: 131
  • Unch: 448

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.083-
Genting Sing0.760+0.015
SingHaiyi0.117-
CapLand IntCom T2.060-0.010
Singtel2.380-
Metal Component0.047-0.003
HGH0.019-
Golden Agri-Res0.235+0.010
HPH Trust USD0.230+0.005
Mapletree Log Tr1.870-

World Indices

World Indices
Name Last Change
Nasdaq 15,537.7 -245.1
HSI 23,766.7 -22.2
HSCEI 8,455.5 -50.9
Jakarta 6,538.5 -45.3
Nikkei 225 27,935.6
SSE Comp 3,607.4 +33.6
Shanghai A 3,781.0 +35.2
Shanghai B 286.0 +2.9
KOSPI 2,968.3 +23.1

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NEOGENOMICS INC NEOGENOMICS INC
Updated on 03 Dec 2021 (End of trading day)
Last (USD): 30.490 Change: -1.850 High: 32.810 Remarks: -
Change (%): -5.72 Low: 30.150

Company Background

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.03389 Trailing EPS (USD) b 0.40919 NAV (USD) c 9.2367
PE a 899.675 Trailing PE d 74.513 Price / NAV c 3.3010
Dividend Yield (%) e - Cash In Hand (USD) f 2.7661 Issued & Paid-up Shares g 123,122,000
Piotroski F Score 3 Market Cap (M) 3,753.990 Free Float (%) 95.6
Return on Equity (ROE) (%) h 4.430 Revenue Growth (%) TTM i 13.937
Net Earnings Growth (%) j 1,117.983 Net Debt/Equity k 0.062
Sector & Industry Health Services - Medical/Nursing Services
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 08 Nov 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --6.160
-16.81 %
10 Days --9.540
-23.83 %
20 Days --10.890
-26.32 %
Medium Term Return 3 Months --20.870
-40.63 %
6 Months --10.410
-25.45 %
1 Year --17.520
-36.49 %
Long Term Return 2 Years -+3.870
+14.54 %
3 Years -+16.300
+114.87 %
5 Years -+21.070
+223.67 %
Annualised Return Annualised --
+26.48 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NEOGENOMICS INC NASDAQ 3,753.990 899.675 74.513 3.3010 -
Industry Medical/Nursing Services NASDAQ 1,479.129 - - 3.6951 0.017
Local Peer GUARDANT HEALTH INC NASDAQ 9,220.199 - - 12.9969 -
Local Peer NATERA INC NASDAQ 8,188.126 - - 10.7878 -
Local Peer ACADIA HEALTHCARE NASDAQ 5,053.481 25.890 23.153 2.0758 -
Local Peer AMEDISYS INC NASDAQ 4,444.359 24.206 20.185 4.9095 -
Local Peer OPTION CARE HEALTH INC NASDAQ 4,415.931 - 53.676 4.0237 -
Local Peer ENSIGN GROUP INC NASDAQ 4,172.290 24.474 21.704 4.2609 0.265
Local Peer LHC GROUP INC NASDAQ 3,528.488 31.618 27.056 2.1650 -
Local Peer LIFESTANCE HEALTH GROUP INC NASDAQ 3,243.872 - - 2.0998 -
Local Peer 1LIFE HEALTHCARE INC NASDAQ 2,947.326 - - 1.6487 -
Local Peer FULGENT GENETICS INC NASDAQ 2,440.217 11.160 4.301 2.3537 -
Local Peer RADNET INC NASDAQ 1,443.325 - 41.828 6.4195 -
Local Peer ADDUS HOMECARE CORP NASDAQ 1,348.732 40.707 33.288 2.4169 -
Other Local Peers TIVITY HEALTH INC (NASDAQ), AVEANNA HEALTHCARE HOLDINGS INC (NASDAQ), SMILEDIRECTCLUB INC (NASDAQ), BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A (NASDAQ), CASTLE BIOSCIENCES INC (NASDAQ), APRIA INC (NASDAQ), GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), FINCH THERAPEUTICS GROUP INC (NASDAQ), PENNANT GROUP INC (NASDAQ), THE ONCOLOGY INSTITUTE INC (NASDAQ), PROGENITY INC (NASDAQ), GLOBAL X FDS ARTIFICIAL INTELLIGENCE AND TECH ETF (NASDAQ), TALKSPACE INC (NASDAQ), SERA PROGNOSTICS INC (NASDAQ), CARDIFF ONCOLOGY INC (NASDAQ), SANARA MEDTECH INC (NASDAQ), FIELD TRIP HEALTH LTD (NASDAQ), EXAGEN INC (NASDAQ), BIODESIX INC (NASDAQ), APTINYX INC (NASDAQ), AKUMIN INC (NASDAQ), OPTINOSE INC (NASDAQ), ONTRAK INC (NASDAQ), GREENBROOK TMS INC (NASDAQ), PRO-DEX INC (NASDAQ), BIOCEPT INC (NASDAQ), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), ONCOSEC MEDICAL INCORPORATED (NASDAQ), NOVO INTEGRATED SCIENCES INC (NASDAQ), IMAC HOLDINGS INC (NASDAQ), GBS INC (NASDAQ), GUARDION HEALTH SCIENCES INC (NASDAQ)
Global Peer JD HEALTH INTERNATIONAL INC HKEx 201,697.221 - - 4.2431 -
Global Peer FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV NYSE 17,826.394 13.430 16.261 1.2577 -
Global Peer SONIC HEALTHCARE ASX 20,443.290 15.546 15.546 3.2018 2.127
Global Peer DAVITA INC NYSE 10,071.796 12.858 10.232 8.7624 -
Global Peer AGILON HEALTH INC NYSE 8,510.821 - - 7.5470 -
Global Peer OAK STREET HEALTH INC NYSE 6,842.327 - - 45.3167 -
Global Peer CHEMED CORP NYSE 7,235.496 22.649 23.517 9.2796 0.290
Global Peer CANO HEALTH INC NYSE 4,055.882 - - 13.0603 -
Global Peer INVITAE CORP NYSE 3,393.301 - - 1.0922 -
Global Peer JINXIN FERTILITY GROUP LTD HKEx 25,690.827 90.861 75.153 2.5285 -
Other Global Peers MEDNAX INC (NYSE), HEALIUS LTD (ASX), EC HEALTHCARE (HKEx), NEW HORIZON HEALTH LTD (HKEx), SVH (SET), Metro Healthcare Indonesia Tbk. (IDX), US PHYSICAL THERAPY (NYSE), RAM (SET), KPJ (Bursa), C-MER EYE CARE HLDGS LTD (HKEx), ATI PHYSICAL THERAPY INC (NYSE), HANGER INC (NYSE), OCEANIA HEALTHCARE LTD (ASX), AUSTRALIAN CLINICA (ASX), CHAOJU EYE CARE HOLDINGS LTD (HKEx), KINDSTAR GLOBALGENE TECHNOLOGY INC (HKEx), GLOBAL CORD BLOOD CORPORATION (NYSE), TOWN HEALTH INTL MEDICAL GP LTD (HKEx), EUROEYES INTL EYE CLINIC LTD (HKEx), TalkMed (SGX), UPHEALTH INCORPORATED (NYSE), VIRTUS HEALTH LIMITED (ASX), SONIDA SENIOR LIVING INC (NYSE), CLOVER CORP (ASX), HEALTHIA LTD (ASX), SILK LASER AUSTRALIA LTD (ASX), GUANGDONG KANGHUA HEALTHCARE CO LTD (HKEx), OPTIMAX (Bursa), KATO (HK) HOLDINGS LTD (HKEx), UMP HEALTHCARE HOLDINGS LIMITED (HKEx), RAILY AESTHETIC MEDICINE INTL HLDGS (HKEx), Cordlife (SGX), BARD1 LIFE SCIENCES LTD (ASX), MHCARE (Bursa), Diagnos Laboratorium Utama Tbk. (IDX), ORTHOCELL LIMITED (ASX), HUMAN HEALTH HOLDINGS LTD (HKEx), Asian Healthcare (SGX), HC Surgical (SGX), CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) (NYSE), SPLASH BEVERAGE GROUP INC (NYSE American), Clearbridge (SGX), KDH (SET), CHINA HEALTH GROUP LTD (HKEx), REPUBLIC HEALTHCARE LTD (HKEx), D (SET), Alliance HC (SGX), Sing Paincare (SGX), Medinex (SGX), BCAL DIAGNOSTICS LIMITED (ASX), SMILE (Bursa), RMH HLDGS LTD (HKEx), CHINA WAH YAN HEALTHCARE LIMITED (HKEx), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), AsiaMedic (SGX), TOTAL BRAIN LTD (ASX), RHT HealthTrust (SGX), MEDINET GROUP LTD (HKEx), MOHO RESOURCES NL (ASX), SMILES INCLUSIVE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.